Aurobindo Pharma recalls 88,600 vials of Lidocaine injections from US market

20 Apr 2019 Evaluate

Aurobindo Pharma has initiated recall of 88,600 vials of Lidocaine HCI Injection, USP 1% 50 mg/5 mL (10 mg/mL) from USA market as one of the vials contained a strand of hair. According to a notification by the US Drug regulator, these vials were manufactured in India for AuroMedics Pharna LLC.

Lidocaine HCI injection is a medication used for local or regional anaesthesia to perform certain surgeries and procedures.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1163.70 -8.60 (-0.73%)
19-Jan-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1663.00
Dr. Reddys Lab 1175.15
Cipla 1381.95
Zydus Lifesciences 863.85
Lupin 2165.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×